eCQM Title | Diabetes: Medical Attention for Nephropathy |
||
---|---|---|---|
eCQM Identifier (Measure Authoring Tool) | 134 | eCQM Version Number | 11.0.000 |
NQF Number | Not Applicable | GUID | 7b2a9277-43da-4d99-9bee-6ac271a07747 |
Measurement Period | January 1, 20XX through December 31, 20XX | ||
Measure Steward | National Committee for Quality Assurance | ||
Measure Developer | National Committee for Quality Assurance | ||
Endorsed By | None | ||
Description |
The percentage of patients 18-75 years of age with diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement period |
||
Copyright |
This Physician Performance Measure (Measure) and related data specifications are owned and were developed by the National Committee for Quality Assurance (NCQA). NCQA is not responsible for any use of the Measure. NCQA makes no representations, warranties, or endorsement about the quality of any organization or physician that uses or reports performance measures and NCQA has no liability to anyone who relies on such measures or specifications. NCQA holds a copyright in the Measure. The Measure can be reproduced and distributed, without modification, for noncommercial purposes (e.g., use by healthcare providers in connection with their practices) without obtaining approval from NCQA. Commercial use is defined as the sale, licensing, or distribution of the Measure for commercial gain, or incorporation of the Measure into a product or service that is sold, licensed or distributed for commercial gain. All commercial uses or requests for modification must be approved by NCQA and are subject to a license at the discretion of NCQA. (C) 2012-2021 National Committee for Quality Assurance. All Rights Reserved. Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets. NCQA disclaims all liability for use or accuracy of any third party codes contained in the specifications. CPT(R) contained in the Measure specifications is copyright 2004-2021 American Medical Association. LOINC(R) copyright 2004-2021 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2021 International Health Terminology Standards Development Organisation. ICD-10 copyright 2021 World Health Organization. All Rights Reserved. |
||
Disclaimer |
The performance Measure is not a clinical guideline and does not establish a standard of medical care, and has not been tested for all potential applications. THE MEASURE AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND. Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM]. |
||
Measure Scoring | Proportion | ||
Measure Type | Process | ||
Stratification |
None |
||
Risk Adjustment |
None |
||
Rate Aggregation |
None |
||
Rationale |
Diabetes is the seventh leading cause of death in the United States. In 2017, diabetes affected approximately 34 million Americans (10.5 percent of the U.S. population) and killed approximately 84,000 people (Centers for Disease Control and Prevention [CDC], 2020a). Diabetes is a long-lasting disease marked by high blood glucose levels, resulting from the body's inability to produce or use insulin properly (CDC, 2020b). People with diabetes are at increased risk of serious health complications including vision loss, heart disease, stroke, kidney damage, amputation of feet or legs, and premature death (CDC, 2021a). In 2017, diabetes cost the U.S. an estimated $327 billion: $237 billion in direct medical costs and $90 billion in reduced productivity. This is a 34 percent increase from the estimated $245 billion spent on diabetes in 2012 (American Diabetes Association [ADA], 2018). Diabetes is the leading cause of chronic kidney disease (CKD) (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2017). About 1 in 3 adults with diabetes has CKD, which increases their risk of heart disease, stroke, and kidney failure (CDC, 2021b). Managing diabetes, including blood sugar and blood pressure control, can slow or prevent diabetes-related CKD (NIDDK, 2017). |
||
Clinical Recommendation Statement |
American Diabetes Association (2021): Screening - At least annually, urinary albumin (e.g., spot urinary albumin-to-creatinine ratio [UACR]) and estimated glomerular filtration rate (eGFR) should be assessed in patients with type 1 diabetes with duration of >=5 years and in all patients with type 2 diabetes, regardless of treatment. (Level of evidence: B) - Patients with urinary albumin >300 mg/g creatinine and/or an eGFR 30-60 mL/min/1.73m2 should be monitored twice annually to guide therapy. (Level of evidence: B) Treatment - An angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) is not recommended for the primary prevention of chronic kidney disease in patients with diabetes who have normal blood pressure, normal UACR (<30 mg/g creatinine), and normal GFR. (Level of evidence: A) - In nonpregnant patients with diabetes and hypertension, either an ACE inhibitor or ARB is recommended for those with modestly elevated UACR (30-299 mg/g creatinine) (Level of evidence: B) and is strongly recommended for those with UACR >=300 mg/g creatinine and/or eGFR <60 mL/min/1.73.m2. (Level of evidence: A) - Periodically monitor serum creatinine and potassium levels for the development of increased creatinine or changes in potassium when ACE inhibitors, ARB, or diuretics are used. (Level of evidence: B) -Patients should be referred for evaluation by a nephrologist if they have an eGFR <30 mL/min/1.73 m2. (Level of evidence: A) -Promptly refer to a physician experienced in the care of kidney disease for uncertainty about the etiology of kidney disease, difficult management issues, and rapidly progressing kidney disease. (Level of evidence: A) American Association of Clinical Endocrinologists & American College of Endocrinology (2015): - Beginning 5 years after diagnosis in patients with type 1 diabetes (if diagnosed before age 30) or at diagnosis in patients with type 2 diabetes and those with type 1 diabetes diagnosed after age 30, annual assessment of serum creatinine to determine the estimated glomerular filtration rate (eGFR) and urine albumin excretion rate (AER) should be performed to identify, stage, and monitor progression of diabetic nephropathy. (Grade C; best evidence level 3) - Patients with nephropathy should be counseled regarding the need for optimal glycemic control, blood pressure control, dyslipidemia control, and smoking cessation. (Grade B; best evidence level 2) - In addition, they should have routine monitoring of albuminuria, kidney function electrolytes, and lipids. (Grade B; best evidence level 2) - Associated conditions such as anemia and bone and mineral disorders should be assessed as kidney function declines. (Grade D; best evidence level 4) - Referral to a nephrologist is recommended well before the need for renal replacement therapy. (Grade D; best evidence level 4) |
||
Improvement Notation |
Higher score indicates better quality |
||
Reference |
Reference Type: CITATION Reference Text: 'American Association of Clinical Endocrinologists And American College of Endocrinology. (2015). Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan—2015. Endocrine Practice, 21(Suppl. 1). https://doi.org/10.4158/EP15672.GLSUPPL' |
||
Reference |
Reference Type: CITATION Reference Text: 'American Diabetes Association. (2018). Economic Costs of Diabetes in the U.S. in 2017. Diabetes Care, 41, 917-928. Retrieved from http://care.diabetesjournals.org/content/early/2018/03/20/dci18-0007' |
||
Reference |
Reference Type: CITATION Reference Text: 'American Diabetes Association. (2021). 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes–20202021. Diabetes Care 20202021; 4344(Suppl. 1):S135151–S151167. https://doi.org/10.2337/dc21-S011' |
||
Reference |
Reference Type: CITATION Reference Text: 'Centers for Disease Control and Prevention. (2020a). National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services. Retrieved from https://www.cdc.gov/diabetes/data/statistics-report/index.html' |
||
Reference |
Reference Type: CITATION Reference Text: 'Centers for Disease Control and Prevention. (2021a). Diabetes Report Card 2019. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services. Retrieved from https://www.cdc.gov/diabetes/library/reports/reportcard.html' |
||
Reference |
Reference Type: CITATION Reference Text: 'Centers for Disease Control and Prevention. (2021b). Chronic Kidney Disease in the United States, 2021. Retrieved from https://www.cdc.gov/kidneydisease/pdf/Chronic-Kidney-Disease-in-the-US-2021-h.pdf' |
||
Reference |
Reference Type: CITATION Reference Text: 'National Institute of Diabetes and Digestive and Kidney Diseases. (2017). Diabetic Kidney Disease. Retrieved from https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/diabetic-kidney-disease#keephealthy' |
||
Definition |
None |
||
Guidance |
This eCQM is a patient-based measure. This version of the eCQM uses QDM version 5.6. Please refer to the eCQI resource center (https://ecqi.healthit.gov/qdm) for more information on the QDM. |
||
Transmission Format |
TBD |
||
Initial Population |
Patients 18-75 years of age by the end of the measurement period, with diabetes with a visit during the measurement period |
||
Denominator |
Equals Initial Population |
||
Denominator Exclusions |
Exclude patients who are in hospice care for any part of the measurement period. Exclude patients 66 and older by the end of the measurement period who are living long term in a nursing home any time on or before the end of the measurement period. Exclude patients 66 and older by the end of the measurement period with an indication of frailty for any part of the measurement period who also meet any of the following advanced illness criteria: - Advanced illness with two outpatient encounters during the measurement period or the year prior - OR advanced illness with one inpatient encounter during the measurement period or the year prior - OR taking dementia medications during the measurement period or the year prior Exclude patients receiving palliative care for any part of the measurement period. |
||
Numerator |
Patients with a screening for nephropathy or evidence of nephropathy during the measurement period |
||
Numerator Exclusions |
Not Applicable |
||
Denominator Exceptions |
None |
||
Supplemental Data Elements |
For every patient evaluated by this measure also identify payer, race, ethnicity and sex |
AgeInYearsAt(date from end of "Measurement Period" )in Interval[18, 75] and exists ( "Qualifying Encounters" ) and exists ( ["Diagnosis": "Diabetes"] Diabetes where Diabetes.prevalencePeriod overlaps "Measurement Period" )
"Initial Population"
Hospice."Has Hospice Services" or AIFrailLTCF."Is Age 66 or Older with Advanced Illness and Frailty" or AIFrailLTCF."Is Age 66 or Older Living Long Term in a Nursing Home" or PalliativeCare."Palliative Care in the Measurement Period"
exists ( "Active ACE or ARB Medications" ) or exists ( "Nephropathy Diagnoses" ) or exists ( "Nephropathy Screenings" )
None
None
None
["Medication, Active": "ACE Inhibitor or ARB or ARNI"] ACEorARBMedication where Global."NormalizeInterval" ( ACEorARBMedication.relevantDatetime, ACEorARBMedication.relevantPeriod ) overlaps "Measurement Period"
exists ( ["Device, Order": "Frailty Device"] FrailtyDeviceOrder where FrailtyDeviceOrder.authorDatetime during day of "Measurement Period" ) or exists ( ["Assessment, Performed": "Medical equipment used"] EquipmentUsed where EquipmentUsed.result in "Frailty Device" and Global."NormalizeInterval" ( EquipmentUsed.relevantDatetime, EquipmentUsed.relevantPeriod ) ends during day of "Measurement Period" ) or exists ( ["Diagnosis": "Frailty Diagnosis"] FrailtyDiagnosis where FrailtyDiagnosis.prevalencePeriod overlaps "Measurement Period" ) or exists ( ["Encounter, Performed": "Frailty Encounter"] FrailtyEncounter where FrailtyEncounter.relevantPeriod overlaps "Measurement Period" ) or exists ( ["Symptom": "Frailty Symptom"] FrailtySymptom where FrailtySymptom.prevalencePeriod overlaps "Measurement Period" )
exists (["Medication, Active": "Dementia Medications"] DementiaMedication where Global."NormalizeInterval" ( DementiaMedication.relevantDatetime, DementiaMedication.relevantPeriod ) overlaps Interval[start of "Measurement Period" - 1 year, end of "Measurement Period"])
exists( ["Encounter, Performed": "Acute Inpatient"] InpatientEncounter where exists ( InpatientEncounter.diagnoses Diagnosis where Diagnosis.code in "Advanced Illness" ) and InpatientEncounter.relevantPeriod starts during day of Interval[start of "Measurement Period" - 1 year, end of "Measurement Period"])
exists ( from "Outpatient Encounters with Advanced Illness" OutpatientEncounter1, "Outpatient Encounters with Advanced Illness" OutpatientEncounter2 where OutpatientEncounter2.relevantPeriod ends 1 day or more after day of end of OutpatientEncounter1.relevantPeriod return OutpatientEncounter1 )
( AgeInYearsAt(date from end of "Measurement Period" )>= 66 ) and ( ( Last(["Assessment, Performed": "Housing status"] HousingStatus where Global."NormalizeInterval"(HousingStatus.relevantDatetime, HousingStatus.relevantPeriod)ends on or before end of "Measurement Period" sort by end of Global."NormalizeInterval"(relevantDatetime, relevantPeriod)asc )) LastHousingStatus where LastHousingStatus.result ~ "Lives in a nursing home (finding)" ) is not null
( AgeInYearsAt(date from end of "Measurement Period" )>= 66 and "Has Criteria Indicating Frailty" and ( "Has Two Outpatient Encounters with Advanced Illness on Different Dates of Service" or "Has Inpatient Encounter with Advanced Illness" or "Has Dementia Medications in Year Before or During Measurement Period" ) )
( ["Encounter, Performed": "Outpatient"] union ["Encounter, Performed": "Observation"] union ["Encounter, Performed": "Emergency Department Visit"] union ["Encounter, Performed": "Nonacute Inpatient"] ) OutpatientEncounter where exists ( OutpatientEncounter.diagnoses Diagnosis where Diagnosis.code in "Advanced Illness" ) and OutpatientEncounter.relevantPeriod starts during day of Interval[start of "Measurement Period" - 1 year, end of "Measurement Period"]
"Initial Population"
Hospice."Has Hospice Services" or AIFrailLTCF."Is Age 66 or Older with Advanced Illness and Frailty" or AIFrailLTCF."Is Age 66 or Older Living Long Term in a Nursing Home" or PalliativeCare."Palliative Care in the Measurement Period"
["Encounter, Performed": "ESRD Monthly Outpatient Services"]
exists ( ["Encounter, Performed": "Encounter Inpatient"] InpatientEncounter where ( InpatientEncounter.dischargeDisposition ~ "Discharge to home for hospice care (procedure)" or InpatientEncounter.dischargeDisposition ~ "Discharge to healthcare facility for hospice care (procedure)" ) and InpatientEncounter.relevantPeriod ends during day of "Measurement Period" ) or exists ( ["Encounter, Performed": "Hospice Encounter"] HospiceEncounter where HospiceEncounter.relevantPeriod overlaps "Measurement Period" ) or exists ( ["Assessment, Performed": "Hospice care [Minimum Data Set]"] HospiceAssessment where HospiceAssessment.result ~ "Yes (qualifier value)" and Global."NormalizeInterval" ( HospiceAssessment.relevantDatetime, HospiceAssessment.relevantPeriod ) overlaps "Measurement Period" ) or exists ( ["Intervention, Order": "Hospice Care Ambulatory"] HospiceOrder where HospiceOrder.authorDatetime during day of "Measurement Period" ) or exists ( ["Intervention, Performed": "Hospice Care Ambulatory"] HospicePerformed where Global."NormalizeInterval" ( HospicePerformed.relevantDatetime, HospicePerformed.relevantPeriod ) overlaps "Measurement Period" )
AgeInYearsAt(date from end of "Measurement Period" )in Interval[18, 75] and exists ( "Qualifying Encounters" ) and exists ( ["Diagnosis": "Diabetes"] Diabetes where Diabetes.prevalencePeriod overlaps "Measurement Period" )
( ["Diagnosis": "Hypertensive Chronic Kidney Disease"] union ["Diagnosis": "Kidney Failure"] union ["Diagnosis": "Glomerulonephritis and Nephrotic Syndrome"] union ["Diagnosis": "Diabetic Nephropathy"] union ["Diagnosis": "Proteinuria"] ) NephropathyDiagnoses where NephropathyDiagnoses.prevalencePeriod overlaps "Measurement Period"
( ( "Renal Procedures" union "Renal Interventions" union "Protein Urea Lab Test" ) ScreeningNephropathy where Global."NormalizeInterval" ( ScreeningNephropathy.relevantDatetime, ScreeningNephropathy.relevantPeriod ) during day of "Measurement Period" ) union ( "End Stage Renal Disease Encounter" ESRDEncounter where ESRDEncounter.relevantPeriod during day of "Measurement Period" )
exists ( "Active ACE or ARB Medications" ) or exists ( "Nephropathy Diagnoses" ) or exists ( "Nephropathy Screenings" )
exists ( ["Assessment, Performed": "Functional Assessment of Chronic Illness Therapy - Palliative Care Questionnaire (FACIT-Pal)"] PalliativeAssessment where Global."NormalizeInterval"(PalliativeAssessment.relevantDatetime, PalliativeAssessment.relevantPeriod) overlaps "Measurement Period" ) or exists (["Diagnosis": "Encounter for palliative care"] PalliativeDiagnosis where PalliativeDiagnosis.prevalencePeriod overlaps "Measurement Period") or exists ( ["Encounter, Performed": "Palliative Care Encounter"] PalliativeEncounter where PalliativeEncounter.relevantPeriod overlaps "Measurement Period" ) or exists ( ["Intervention, Performed": "Palliative Care Intervention"] PalliativeIntervention where Global."NormalizeInterval"(PalliativeIntervention.relevantDatetime, PalliativeIntervention.relevantPeriod) overlaps "Measurement Period" )
["Laboratory Test, Performed": "Urine Protein Tests"] ProteinUreaResult where ProteinUreaResult.result is not null
( ["Encounter, Performed": "Office Visit"] union ["Encounter, Performed": "Annual Wellness Visit"] union ["Encounter, Performed": "Preventive Care Services Established Office Visit, 18 and Up"] union ["Encounter, Performed": "Preventive Care Services Initial Office Visit, 18 and Up"] union ["Encounter, Performed": "Home Healthcare Services"] union ["Encounter, Performed": "Telephone Visits"] ) ValidEncounters where ValidEncounters.relevantPeriod during day of "Measurement Period"
["Intervention, Performed": "Other Services Related to Dialysis"] union ["Intervention, Performed": "Dialysis Education"]
( ["Procedure, Performed": "Kidney Transplant"] union ["Procedure, Performed": "Dialysis Services"] )
["Patient Characteristic Ethnicity": "Ethnicity"]
["Patient Characteristic Payer": "Payer"]
["Patient Characteristic Race": "Race"]
["Patient Characteristic Sex": "ONC Administrative Sex"]
if pointInTime is not null then Interval[pointInTime, pointInTime] else if period is not null then period else null as Interval<DateTime>
["Patient Characteristic Ethnicity": "Ethnicity"]
["Patient Characteristic Payer": "Payer"]
["Patient Characteristic Race": "Race"]
["Patient Characteristic Sex": "ONC Administrative Sex"]
Measure Set |
None |
---|